Geometry Dash APK Hill Climb Racing APK
35.8 F
New York
Friday, December 9, 2022

Looking Into the Buzz Propelling Mind Medicine Inc (OTCMKTS:MMEDF)

Must read

Asia Broadband Inc (OTCMKTS:AABB) Is Up 1100% This year: What’s The Buzz?

There are some stocks that have managed to clock massive over the course of the past month or so and one of...

Blockchain Technologies Ltd (OTCMKTS:HVBTF) Makes A Stunning Move on Blockchain Optimism

The cryptocurrency boom has sustained for many months now and it anything; it is expected to continue in the future.

Bombardier, Inc. (OTCMKTS:BDRBF) Continues to Gain Momentum and Strength

Many stocks have managed to record significant gains in recent months and one that often flies under the radar is Bombardier,...

Grayscale Bitcoin Trust (Btc) (GBTC) Makes Big Move As Bitcoin Goes Wild

Bitcoin, the world’s biggest cryptocurrency by market cap, has been in the middle of a remarkable rally for the past few months...

Over course of the past couple of months, psychedelics-based medicine manufacturer Mind Medicine (MindMed) Inc (OTCMKTS:MMEDF) has seen its stock made massive gains.

Since the middle of September, MMEDF stock has rallied by as much as 400% owing to certain favorable developments and perhaps it’s time for tardy investors to take a closer look at it.

Launch Of Albert

Last Tuesday, the company made another major announcement. Mind Medicine announced the launch of Albert, a new digital division of its business. It is a major development for the company and the news resulted in another strong rally in the stock as well.

Albert is going to be involved in the development of an integrated platform that is going to help in the delivery of psychedelics based medicines. It is a bold move from the company and creates another avenue through which it can sell its products. The platform in question is also going to have a toolset that will further enhance the service provided by the delivery system.

The company believes that the combination of digital solutions with psychedelics based medicines can prove to be a major boon for healthcare professionals. J.R. Rahn, the co-Chief Executive Officer of the company stated that it is the ‘next frontier’ in the psychedelics-based medicines space.

Earlier this month, the company received another boost. Mind Medicine announced that it received approval from the healthcare regulators in Switzerland and the Netherlands with regards to one of its clinical trials.

The approval pertains to the Phase 2A clinical trial to check if ADHD among adults can be treated with microdoses of LSD. It is a step in the right direction for Mind Medicine and the developments are almost certain to be watched closely by investors.

Mind Medicine had earlier reached an agreement with University Hospital Basel Liechti Lab for conducting Phase 2A clinical trial for treating anxiety disorders with LSD.

Latest article

Alibaba Group Holding Limited (OTCMKTS:BABAF) Big Volume with Possible 60% Upside

Alibaba Group Holding Limited (OTCMKTS:  BABAF) is an over the counter stock traded on the OTC Pink markets in the Consumer Discretionary...

Trans Global Group Inc (OTCMKTS:TGGI) Stock In Focus After Operational Updates

The Trans Global Group Inc (OTCMKTS:TGGI) stock may not have been in the news today yet but it...

Why Hycroft Mining (NASDAQ:HYMC) Stock Shot Up 700%

If you are on the hunt for stocks that may have made major gains over the course of the past week, then...

Secure Paymentz releases banking software demo on Github

This is a paid announcement from one of our advertising partners. How to Leverage Your Trading Position by Secure...

Advanced Asset Management Announces New Website Launch

This is a paid announcement from one of our advertising partners. Financial Planner in Grandville, Michigan
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service